Ozempic vs Wegovy: Same Ingredient, Very Different Purposes

Published 12 July 2026  ·  7 min read

Walk into almost any conversation about weight loss medication right now and someone will bring up Ozempic. But the drug that's become a household name is often confused — sometimes even by the people taking it — with Wegovy, which is a different product containing the same active ingredient. They're related, but they're not the same thing, and the difference matters in ways that aren't immediately obvious.

Here's a clear-eyed breakdown of what separates them.

The One Thing They Share

Both Ozempic and Wegovy contain semaglutide — a GLP-1 receptor agonist made by the Danish pharmaceutical company Novo Nordisk. Semaglutide mimics a naturally occurring gut hormone called glucagon-like peptide-1. It slows gastric emptying, reduces appetite, and in people with type 2 diabetes, helps regulate blood sugar. The molecule is identical in both products. The pharmacology is the same. The delivery mechanism — a weekly subcutaneous injection — is the same.

What differs is the approved indication, the maximum dose, and as a result, the clinical outcomes each product was studied and approved for.

What Each Drug Is Approved For

Ozempic is approved for the management of type 2 diabetes. More specifically, it's indicated to improve glycaemic control (blood sugar) in adults with T2D, and to reduce the risk of major adverse cardiovascular events in people with T2D who also have established cardiovascular disease. Weight loss happens — sometimes significantly — but it's a secondary effect, not the primary approval.

Wegovy is approved specifically for chronic weight management. Its approval covers adults with a BMI of 30 or above, or 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension or obstructive sleep apnoea. The weight loss trials that supported Wegovy's approval ran for 68 weeks and involved people who did not necessarily have diabetes.

The Dose Difference

This is where things get meaningful. Ozempic's maximum approved dose is 2mg per week. Wegovy's maximum dose is 2.4mg per week. That 0.4mg difference might sound negligible, but in clinical trials, each 0.5mg step up in semaglutide dose produced additional weight loss. The 2.4mg dose used in the Wegovy trials produced greater weight loss than any prior semaglutide dose studied.

Why Are People Being Prescribed Ozempic for Weight Loss?

This is very common, particularly in countries where Wegovy isn't yet available or isn't covered by insurance. Off-label prescribing of Ozempic for weight loss is legal in most places and medically defensible — the pharmacology supports it. In practice, many people prescribed Ozempic for weight loss follow a similar escalation and achieve significant results.

However, there are a few things worth knowing if you're in this situation. First, the weight-loss clinical trial data was generated using Wegovy at 2.4mg, not Ozempic. Using Ozempic at its maximum 2mg dose may produce less weight loss on average than Wegovy at 2.4mg, though individual results vary considerably. Second, if your prescriber is using Ozempic off-label for weight loss, your insurance may not cover it under the same criteria it would apply to Wegovy — coverage rules differ by insurer and jurisdiction.

What About the Shortage?

Both Ozempic and Wegovy have experienced significant supply shortages as demand has outpaced manufacturing capacity. At various times in different countries, one has been available while the other hasn't. This has contributed to the blurring of the two brands in public understanding — people end up on whichever one their pharmacy has, or their insurer will cover, or their prescriber has access to.

From a tracking and monitoring perspective, it doesn't matter which product you're using. What matters is logging the dose you actually took and when you took it.

Which Should I Be On?

That depends on why you're taking it. If you have type 2 diabetes, Ozempic is the on-label choice and will likely be your insurer's preference. If your primary goal is weight loss and you don't have T2D, Wegovy is the on-label option — though cost and availability vary significantly by country.

If Wegovy isn't available or affordable in your situation, your prescriber may offer Ozempic as an off-label alternative. The weight loss you'll achieve will depend on the dose you can reach, the lifestyle changes you make alongside it, and your individual response to semaglutide — not the brand name on the box.

The Bottom Line

Same molecule. Different doses. Different approved uses. Ozempic tops out at 2mg and was approved for type 2 diabetes — weight loss is a significant side effect. Wegovy tops out at 2.4mg and was specifically approved for weight management, with trial data that backs it up. If you're taking either, tracking your doses and weight over time is one of the most useful things you can do to stay on top of your progress and give your prescriber the information they need.

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Medication decisions should always be made in consultation with a qualified healthcare professional who understands your individual circumstances.